Letter by Bonello et al Regarding Article, “Early Versus Standard Care Invasive Examination and Treatment of Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial”

Laurent Bonello; Marc Laine; Gilles Lemesle

doi:10.1161/circulationaha.118.037810

May 13, 2019Circulation

Letter by Bonello et al Regarding Article, “Early Versus Standard Care Invasive Examination and Treatment of Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial”

View at Publisher

Ask AI

Bookmark

Share

Key result

Letter discusses early versus standard invasive care for NSTE-ACS in the VERDICT trial.

Key Points

Key points are not available for this paper at this time.

Implication

Questions VERDICT trial's low recurrent ischemia rate; challenges generalizability of neutral early-invasive result in NSTE-ACS.

Abstract

International audience

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bonello et al. (2019) studied this question. Early versus standard care invasive examination for non-ST-segment elevation acute coronary syndrome is the subject of a letter by Bonello et al discussing the VERDICT trial.

synapsesocial.com/papers/6aaf780d1512dcc6655d2edf https://doi.org/10.1161/circulationaha.118.037810

View at Publisher

Ask AI

Bookmark

Share

Letter by Bonello et al Regarding Article, “Early Versus Standard Care Invasive Examination and Treatment of Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial”

Key Points

Implication

Abstract

Discussion

Cite This Study

Letter by Bonello et al Regarding Article, “Early Versus Standard Care Invasive Examination and Treatment of Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial”

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading